Related Experiment Videos

Activation of phospholipase activity during Semliki Forest virus infection

L Pérez1, A Irurzun, L Carrasco

  • 1Centro de Biología Molecular, Universidad Autónoma de Madrid, Cantoblanco, Spain.

Virology
|May 1, 1993
PubMed

Insights

Viral infection increases cell membrane permeability by activating phospholipases (PLases). This study shows Semliki Forest virus (SFV) infection releases choline and arachidonic acid, blocked by PLase inhibitors, suggesting lipase activation mediates increased permeability.

Area of Science:

  • Cell Biology
  • Virology
  • Biochemistry

Background:

  • Viral infections can increase cell membrane permeability.
  • Semliki Forest virus (SFV) infection alters cell membrane permeability for cations and metabolites.
  • The molecular mechanisms behind virus-induced membrane permeability changes are not fully understood.

Purpose of the Study:

  • To investigate the molecular basis of increased membrane permeability during viral infection.
  • To identify the specific enzymes involved in virus-induced membrane alterations.
  • To explore potential therapeutic interventions targeting these mechanisms.

Main Methods:

  • Infection of HeLa and BHK cells with SFV and vesicular stomatitis virus, respectively.
  • Measurement of choline and arachidonic acid release into culture media.
  • Assay of phospholipase inhibitors (zinc ions, chloroquine, etc.) on cellular responses.
  • Assessment of hygromycin B uptake and its inhibition.

Main Results:

  • SFV infection significantly increases the release of choline and arachidonic acid, indicating activation of phospholipases C and A2.
  • Radioactivity from labeled arachidonic acid was released as free fatty acid, confirming phospholipid hydrolysis.
  • Several phospholipase inhibitors effectively blocked the release of choline and arachidonic acid.
  • Inhibition of hygromycin B uptake by zinc ions or chloroquine suggests lipase activation mediates increased membrane permeability.

Conclusions:

  • Viral infection, specifically by SFV, activates phospholipases C and A2, leading to increased membrane permeability.
  • Lipase activation appears to be a key mechanism underlying virus-induced changes in cell membrane permeability.
  • Specific phospholipase inhibitors can counteract these permeability changes, offering potential therapeutic avenues.

Related Concept Videos